Zim Laboratories

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
111.80
0.25 (0.22%)
BSENSE

Jun 16, 11:40 AM

BSE+NSE Vol: 15.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
374.00
379.00
367.00
398.00
333.00
307.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
374.00
379.00
367.00
398.00
333.00
307.00
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
1.00
-14.00
16.00
-9.00
-1.00
Raw Materials Consumed
171.00
166.00
185.00
182.00
170.00
159.00
Power & Fuel Cost
18.00
17.00
13.00
11.00
9.00
7.00
Employee Cost
63.00
60.00
53.00
49.00
40.00
35.00
Operating Expenses
38.00
32.00
31.00
27.00
23.00
19.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
24.00
24.00
24.00
27.00
32.00
27.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
5.00
6.00
6.00
5.00
5.00
3.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
344.00
335.00
326.00
346.00
292.00
267.00
Operating Profit (PBDIT) excl Other Income
30.00
43.00
41.00
51.00
40.00
39.00
Other Income
11.00
5.00
5.00
6.00
4.00
2.00
Operating Profit (PBDIT)
41.00
49.00
46.00
58.00
45.00
42.00
Interest
13.00
11.00
6.00
5.00
8.00
10.00
Profit before Depriciation and Tax
28.00
38.00
39.00
52.00
37.00
31.00
Depreciation
19.00
20.00
15.00
17.00
16.00
15.00
Profit Before Taxation & Exceptional Items
8.00
18.00
23.00
35.00
21.00
15.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
8.00
18.00
23.00
35.00
21.00
10.00
Provision for Tax
2.00
5.00
6.00
10.00
6.00
2.00
Profit After Tax
5.00
12.00
17.00
24.00
14.00
7.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
169.00
157.00
140.00
116.00
101.00
95.00
Profit Available for appropriations
174.00
169.00
157.00
141.00
116.00
102.00
Appropriations
174.00
169.00
157.00
141.00
116.00
102.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
1.19
2.50
3.54
5.01
2.99
4.50
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -1.22% vs 3.16% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -31.37% vs 5.79% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 15.93% vs 64.46% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -52.01% vs -29.46% in Mar 2025

Compare Profit and Loss Results of Zim Laboratories
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
374.00
198.00
176.00
88.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
374.00
198.00
176.00
88.89%
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
-1.00
-5.00
-500.00%
Raw Materials Consumed
171.00
105.00
66.00
62.86%
Power & Fuel Cost
18.00
2.00
16.00
800.00%
Employee Cost
63.00
11.00
52.00
472.73%
Operating Expenses
38.00
5.00
33.00
660.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
31.00
-7.00
-22.58%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
2.00
3.00
150.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
344.00
166.00
178.00
107.23%
Operating Profit (PBDIT) excl Other Income
30.00
31.00
-1.00
-3.23%
Other Income
11.00
11.00
0.00
0.00%
Operating Profit (PBDIT)
41.00
42.00
-1.00
-2.38%
Interest
13.00
5.00
8.00
160.00%
Profit before Depriciation and Tax
28.00
37.00
-9.00
-24.32%
Depreciation
19.00
3.00
16.00
533.33%
Profit Before Taxation & Exceptional Items
8.00
34.00
-26.00
-76.47%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
34.00
-26.00
-76.47%
Provision for Tax
2.00
9.00
-7.00
-77.78%
Profit After Tax
5.00
24.00
-19.00
-79.17%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
169.00
84.00
85.00
101.19%
Profit Available for appropriations
174.00
110.00
64.00
58.18%
Appropriations
174.00
110.00
64.00
58.18%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.19
16.6
-15.41
-92.83%
Profit And Loss - Net Sales
Net Sales 374.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -1.22% vs 3.16% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -31.37% vs 5.79% in Mar 2025

Profit And Loss - Interest
Interest 13.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.93% vs 64.46% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 5.84 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -52.01% vs -29.46% in Mar 2025